Armenia vs Dominican Republic: Prevalence of hypertension, male
Armenia
48.5%
in 2019
Dominican Republic
49.0%
in 2019
Armenia rank
20th
Dominican Republic rank
18th
Prevalence of hypertension, male over time
- Armenia
- Dominican Republic
How they compare
Dominican Republic currently reports 49.0% against 48.5% in Armenia, a difference of 0.5%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Armenia ahead.
Armenia ranks 20th and Dominican Republic ranks 18th of 192 countries.
Dominican Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Armenia | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 42.1% | 42.5% | 0.4% | Dominican Republic |
| 2000s | 44.3% | 46.5% | 2.2% | Dominican Republic |
| 2010s | 47.3% | 48.8% | 1.5% | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, male, Armenia or Dominican Republic?
- Dominican Republic, at 49.0% against 48.5% in Armenia as of 2019.
- What is the difference in prevalence of hypertension, male between Armenia and Dominican Republic?
- 0.5%, with Dominican Republic ahead.
- How many years of comparable data are there for Armenia and Dominican Republic?
- 30 years are reported by both, from 1990 to 2019.
- How do Armenia and Dominican Republic rank globally for prevalence of hypertension, male?
- Armenia ranks 20th and Dominican Republic ranks 18th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.